Managing bronchospasm with short-acting beta(2)-agonists.
Fitzgerald
Margaret A
MA
Fitzgerald Health Education Associates, Inc., North Andover, Massachusetts, USA.
D000208:Acute Disease; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D001249:Asthma / Q000150:complications*; D001986:Bronchial Spasm / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008875:Middle Aged; D009722:Nurse Practitioners / Q000458:organization & administration*; D024802:Nurse's Role; D009730:Nursing Assessment; D010343:Patient Admission; D010351:Patient Discharge; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods*; D000068299:Salmeterol Xinafoate; D013726:Terbutaline / Q000627:therapeutic use
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D013726:Terbutaline; D000420:Albuterol